Clinical Efficacy of Extracellular Vesicle Therapy in Periodontitis: Reduced Inflammation and Enhanced Regeneration
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25115753 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Miljan Puletic und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Stomatology Pancevo, University Business Academy, 26101 Pancevo, Serbia. Hauptthemen laut MEDLINE: Extracellular Vesicles, Periodontitis, Regeneration, Inflammation. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Periodontitis, a prevalent inflammatory condition, affects the supporting structures of teeth, leading to significant oral health challenges. Traditional treatments have primarily focused on mechanical debridement, antimicrobial therapy, and surgery, which often fail to restore lost periodontal structures. Emerging as a novel approach in regenerative medicine, extracellular vesicle (EV) therapy, including exosomes, leverages nano-sized vesicles known for facilitating intercellular communication and modulating physiological and pathological processes. This study is a proof-of-concept type that evaluates the clinical efficacy of EV therapy as a non-surgical treatment for stage I–III periodontitis, focusing on its anti-inflammatory and regenerative potential. The research involved seven patients undergoing the therapy, and seven healthy individuals. Clinical parameters, including the plaque index, bleeding on probing, probing depth, and attachment level, were assessed alongside cytokine levels in the gingival crevicular fluid. The study found significant improvements in clinical parameters, and a marked reduction in pro-inflammatory cytokines post-treatment, matching the levels of healthy subjects, underscoring the therapy’s ability to not only attenuate inflammation and enhance tissue regeneration, but also highlighting its potential in restoring periodontal health. This investigation illuminates the promising role of EV therapy in periodontal treatment, advocating for a shift towards therapies that halt disease progression and promote structural and functional restoration of periodontal tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Stomatology Pancevo, University Business Academy, 26101 Pancevo, Serbia.
- Department for Research and Development, Clinic Orto MD-Parks Hospital, 21000 Novi Sad, Serbia.
- Hajim School of Engineering, University of Rochester, Rochester, NY 14627, USA.
- Institute for Medical Research, Military Medical Academy, 11000 Belgrade, Serbia.
- Medical Faculty of Military Medical Academy, University of Defense, 11000 Belgrade, Serbia.
- Department of Anatomy, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.
ORCID-Profile: Miljan Puletic, Gordana Velikic, Gordana Supic, Dusica L Maric, Stevan Avramov, Danilo Vojvodic
Zitieren
APA
Puletic, M., Velikic, G., Maric, D. M., Supic, G., Maric, D. L., Radovic, N., Avramov, S., & Vojvodic, D. (2024). Clinical Efficacy of Extracellular Vesicle Therapy in Periodontitis: Reduced Inflammation and Enhanced Regeneration. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25115753
Vancouver
Puletic M, Velikic G, Maric DM, Supic G, Maric DL, Radovic N, et al. Clinical Efficacy of Extracellular Vesicle Therapy in Periodontitis: Reduced Inflammation and Enhanced Regeneration. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25115753
BibTeX
@article{Puletic2024,
author = {Puletic, Miljan and Velikic, Gordana and Maric, Dusan M and Supic, Gordana and Maric, Dusica L and Radovic, Nikola and Avramov, Stevan and Vojvodic, Danilo},
title = {Clinical Efficacy of Extracellular Vesicle Therapy in Periodontitis: Reduced Inflammation and Enhanced Regeneration},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25115753}
}
EUVIMED